QN-247

N/A

Report date: 2024/05/09 13:41:24
NME

Base Information

Drug NameQN-247
Drug Alias NameAptamer linked anti nucleolin - Qualigen TherapeuticsALAN (AS1411-GNP)QN-247REQN-247GNP AS1411 +[8] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionNucleolin inhibitors
TargetsNucleolin
Therapy Area/IndicationsPancreatic NeoplasmsBreast NeoplasmsNeuroblastoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of LouisvilleQualigen Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of LouisvilleQualigen Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsBreast NeoplasmsNeuroblastoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A